Insider Transactions in Q1 2025 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
758
-12.51%
|
$175,098
$231.67 P/Share
|
|
Mar 28
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
2,635
-34.69%
|
$608,685
$231.67 P/Share
|
|
Mar 27
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-8.49%
|
$129,822
$231.67 P/Share
|
|
Mar 27
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+23.88%
|
-
|
|
Mar 27
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-24.6%
|
$312,312
$231.67 P/Share
|
|
Mar 27
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,325
+37.7%
|
-
|
|
Mar 27
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,205
-22.5%
|
$509,355
$231.67 P/Share
|
|
Mar 27
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,840
+33.06%
|
-
|
|
Mar 27
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-6.76%
|
$312,543
$231.67 P/Share
|
|
Mar 27
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
3,325
+14.25%
|
-
|
|
Mar 27
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,630
-8.74%
|
$838,530
$231.67 P/Share
|
|
Mar 27
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
8,305
+16.66%
|
-
|
|
Mar 27
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,584
-11.45%
|
$3,137,904
$231.67 P/Share
|
|
Mar 27
2025
|
Adam H Schechter President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,469
+20.43%
|
-
|
|
Mar 27
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-5.41%
|
$45,738
$231.67 P/Share
|
|
Mar 27
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
688
+15.82%
|
-
|
|
Mar 27
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-11.07%
|
$82,929
$231.67 P/Share
|
|
Mar 27
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,249
+27.81%
|
-
|
|
Mar 27
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,109
-6.17%
|
$487,179
$231.67 P/Share
|
|
Mar 27
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
4,840
+12.41%
|
-
|
|
Mar 05
2025
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
500
-3.66%
|
$127,500
$255.63 P/Share
|
|
Feb 28
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
5,339
-51.84%
|
$1,329,411
$249.23 P/Share
|
|
Feb 28
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,903
+27.48%
|
$511,293
$131.43 P/Share
|
|
Feb 25
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,314
-37.72%
|
$329,814
$251.3 P/Share
|
|
Feb 24
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
226
-4.74%
|
$56,500
$250.4 P/Share
|
|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,413
-41.49%
|
$347,598
$246.1 P/Share
|
|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+29.32%
|
$230,319
$163.63 P/Share
|
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-1.72%
|
$10,045
$245.14 P/Share
|
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123
+4.9%
|
-
|
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55
-1.14%
|
$13,475
$245.14 P/Share
|
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+4.0%
|
-
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-1.37%
|
$300,370
$245.14 P/Share
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,963
+3.21%
|
-
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Open market or private sale
|
Direct |
6,121
-6.61%
|
$1,493,524
$244.62 P/Share
|
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-0.51%
|
$21,070
$245.14 P/Share
|
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+1.89%
|
-
|
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-0.64%
|
$52,185
$245.14 P/Share
|
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
807
+2.36%
|
-
|
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-2.05%
|
$32,830
$245.14 P/Share
|
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+6.75%
|
-
|
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-2.41%
|
$21,070
$245.14 P/Share
|
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+8.3%
|
-
|
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.46%
|
$33,320
$245.14 P/Share
|
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+1.58%
|
-
|
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-1.39%
|
$10,290
$245.14 P/Share
|
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+4.25%
|
-
|
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.57%
|
$23,124
$246.27 P/Share
|
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+2.1%
|
-
|
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
234
-0.71%
|
$57,564
$246.27 P/Share
|
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+2.62%
|
-
|